|
Volumn 20, Issue 11, 2013, Pages 1309-1310
|
Two birds with one stone: Dual p110δ and p110γ inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IDELALISIB;
IPI 145;
IPI 3063;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHATIDYLINOSITOL 3 KINASE P110 GAMMA;
PHOSPHATIDYLINOSITOL 3 KINASE P110 OMEGA;
PHOSPHOTRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
IPI-145;
ISOQUINOLINE DERIVATIVE;
PURINE DERIVATIVE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALLERGIC ASTHMA;
ANTIBODY PRODUCTION;
ARTHRITIS;
ARTICLE;
ASTHMA;
CYTOKINE PRODUCTION;
DRUG BLOOD LEVEL;
ENZYME ACTIVITY;
ENZYME INHIBITION;
EOSINOPHIL;
HUMAN;
IC 50;
LEUKOCYTE ACTIVATION;
LUPUS VULGARIS;
NONHUMAN;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
RHEUMATOID ARTHRITIS;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DISEASE MODEL;
FEMALE;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
AVES;
ANIMALS;
ARTHRITIS;
ASTHMA;
DISEASE MODELS, ANIMAL;
FEMALE;
HUMANS;
ISOQUINOLINES;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PHOSPHATIDYLINOSITOL 3-KINASES;
PURINES;
|
EID: 84888270508
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chembiol.2013.11.002 Document Type: Short Survey |
Times cited : (17)
|
References (13)
|